arrow
I

Ibrahim H. Eissa

al-azhar university
H指数:53
被引数:7,738

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New N-(isoxazol-3-yl)-4-(1,3,4-thiadiazol-3(2H)-yl)benzenesulfonamide derivatives as potent Aurora kinases inhibitors: Design, synthesis and anti-proliferative activity

新型N-(异噁唑-3-基)-4-(1,3,4-噻二唑-3(2H)-基)苯磺酰胺衍生物作为强效Aurora激酶抑制剂:设计、合成及抗增殖活性

2026-05-250
PRE
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer Activity

基于结构的全新色烯衍生物设计及其作为选择性血管内皮生长因子受体-2抑制剂的抗癌机制阐释

2026-05-030
PRE
Design, Computational, Synthesis, and Anti-Cancer Evaluation of a Multifunctional 2,3-Dihydro-1,3,4-Thiadiazole-Benzenesulfonamide Hybrid as a Triple Inhibitor of CAIX, CAXII, and EGFR

设计、计算、合成及抗肿瘤评价:一种作为CAIX、CAXII和EGFR三重抑制剂的2,3-二氢-1,3,4-噻二唑-苯磺酰胺类多功能杂化物

2025-11-010
PRE
New 1,3,4-Thiadiazole-Based Dual B-Raf/VEGFR-2 Inhibitors With Potential Anti-Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations

新型1,3,4-噻二唑基双B-Raf/VEGFR-2抑制剂及其潜在抗乳腺癌活性:设计、合成、体外及计算机模拟评价

2025-09-280
PRE
Development of new thiadiazole-based compounds targeting VEGFR-2: In vitro anticancer evaluation, mechanistic investigations, and in silico studies

基于噻二唑的新化合物靶向VEGFR-2的开发:体外抗肿瘤评价、机制研究和计算机模拟研究

2025-08-090
PRE
Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity

综合计算与生物学评价:具有靶向抗乳腺癌活性的新型噻二唑基VEGFR-2抑制剂的合成

2025-07-230
PRE